BBIO
BridgeBio Pharma·NASDAQ
--
--(--)
--
--(--)
2.43 / 10
Underperform
Technical composite 2.43/10 (Underperform). No bullish signals; both Long Lower Shadow and MACD Golden Cross register low scores (~2.4) with weak win rates. Market shows bearish bias and limited recent activity, indicating heightened downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
MACD Golden Cross
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Long Lower Shadow
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
MACD Golden Cross
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Technical Analysis of BBIO?
- BBIO presents a Underperform setup with a Technical Score of 2.43/10. Key technical indicators highlight an RSI of 58.05 and a MACD of 0.99, with the trend anchored by the 50-Day SMA at 71.68. Traders should monitor key support at 68.81 and resistance at 69.93.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
